Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Item
http://www.wikidata.org/entity/Q37295675
Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.Magnetic resonance imaging in pediatric sickle cell anemia.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Managing sickle cell disease.Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood.Neurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease.Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).Genetic modifiers of sickle cell diseaseCerebrovascular disease associated with sickle cell pulmonary hypertension.Reverse sequestration in a case of sickle crisis.Headache in children with sickle cell disease: prevalence and associated factors.Sickle cell disease: management options and challenges in developing countries.The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.Laboratory and Genetic Biomarkers Associated with Cerebral Blood Flow Velocity in Hemoglobin SC Disease.Multiple complications in a sickle cell disease patient: a case report.The excess burden of stroke in hospitalized adults with sickle cell disease.
P2860

Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.

Item
http://www.wikidata.org/entity/Q37295675
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@en
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@nl
type
label
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@en
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@nl
prefLabel
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@en
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
Stroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
@en
P2093
P304
P31
P433
P478
P577
P698
P921